Literature DB >> 2602776

Serratia bacteremia: review of 118 cases.

H Saito1, L Elting, G P Bodey, P Berkey.   

Abstract

A review was conducted of 118 episodes of serratia bacteremia in cancer patients during a 16-year period. The infection occurred most commonly in patients with acute leukemia. Most patients acquired the infection in the hospital, and 61% had received antibiotic therapy during the preceding 10 days. Fever occurred in 90% of cases and shock in 18%. Thirty-eight percent of patients had concomitant pneumonia. Patients with shock, pneumonia, or hemorrhage had a substantially poorer prognosis. The response rate was 75% for patients who received appropriate antibiotics, 22% for those who received inappropriate antibiotics, and 29% for those who received no antibiotics. Patients who continued to have positive blood culture results while receiving appropriate antibiotic therapy had a poor diagnosis. Patients who received only an aminoglycoside had the poorest response rate among those who received appropriate therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2602776     DOI: 10.1093/clinids/11.6.912

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  10 in total

1.  Serratia sp. bacteremia in Canberra, Australia: a population-based study over 10 years.

Authors:  H J Engel; P J Collignon; P T Whiting; K J Kennedy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-05       Impact factor: 3.267

2.  Serratia rubidaea as an invasive pathogen.

Authors:  P R Ursua; M J Unzaga; P Melero; I Iturburu; C Ezpeleta; R Cisterna
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 3.  Serratia infections: from military experiments to current practice.

Authors:  Steven D Mahlen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  Case-control analysis of endemic Serratia marcescens bacteremia in a neonatal intensive care unit.

Authors:  Matthew J Bizzarro; Louise-Marie Dembry; Robert S Baltimore; Patrick G Gallagher
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11-06       Impact factor: 5.747

5.  Serratia infections in patients with neutropenia.

Authors:  F Hartmann; T Gheorghiu; H Leupold; F Baer; V Diehl
Journal:  Klin Wochenschr       Date:  1991-08-01

6.  Review of Citrobacter bacteremia in cancer patients over a sixteen-year period.

Authors:  G Samonis; E Anaissie; L Elting; G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-06       Impact factor: 3.267

7.  Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin.

Authors:  R Coria-Jiménez; C Ortiz-Torres
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

8.  Risk factors for mortality in patients with Serratia marcescens bacteremia.

Authors:  Sun Bean Kim; Yong Duk Jeon; Jung Ho Kim; Jae Kyoung Kim; Hea Won Ann; Heun Choi; Min Hyung Kim; Je Eun Song; Jin Young Ahn; Su Jin Jeong; Nam Su Ku; Sang Hoon Han; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

9.  Capsule Production and Glucose Metabolism Dictate Fitness during Serratia marcescens Bacteremia.

Authors:  Mark T Anderson; Lindsay A Mitchell; Lili Zhao; Harry L T Mobley
Journal:  MBio       Date:  2017-05-23       Impact factor: 7.867

10.  Draft Genome Sequence of the Serratia rubidaea CIP 103234T Reference Strain, a Human-Opportunistic Pathogen.

Authors:  Rémy A Bonnin; Delphine Girlich; Dilek Imanci; Laurent Dortet; Thierry Naas
Journal:  Genome Announc       Date:  2015-11-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.